Arcus Biosciences (RCUS) Net Equity Issued and Repurchased (2018 - 2026)
Arcus Biosciences' Net Equity Issued and Repurchased came in at $16 million for Q2 2026, up 433.3% from $3 million a year earlier and up 433.3% from the prior quarter.
Arcus Biosciences (RCUS) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Arcus Biosciences reported Net Equity Issued and Repurchased of $313 million, up 108.7% year-over-year; for FY2025, it was $439 million, up 85.2% from FY2024.
- Net Equity Issued and Repurchased has increased in each of the last three years, though with a five-year compound annual growth rate of -6.2% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $237 million in FY2024 (+618.2%), $33 million in FY2023 (+43.5%), $23 million in FY2022 (-90.1%) and $232 million in FY2021 (-61.5%).
- The five-year range for quarterly Net Equity Issued and Repurchased is -$213.91 million (Q4 2021) to $286 million (Q4 2025).
- Year-over-year, Net Equity Issued and Repurchased increased in two of the last seven quarters, with growth averaging 75.8%.
- The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q2 2023 (growth of 475.0%), and the weakest in Q1 2026 (a decline of 97.9%).
- Business Quant data shows RCUS's Net Equity Issued and Repurchased at $3 million (Q1 2026), $286 million (Q4 2025) and $8 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | - |
| 10 | Arcus Biosciences | 2.42 Bn | -713.13 Mn | - | 7.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.00 Mn |
| Jun 30, 2026 | 16.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 286.00 Mn |
| Sep 30, 2025 | 8.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | 142.00 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Mar 31, 2024 | 229.00 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 6.00 Mn |
| Jun 30, 2023 | 23.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 6.00 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | 4.00 Mn |
| Mar 31, 2022 | 10.00 Mn |
| Dec 31, 2021 | -213.91 Mn |
Arcus Biosciences Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RCUS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();